Navellier & Associates’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-18,438
| Closed | -$3.92M | – | 314 |
|
|
2020
Q4 | $3.92M | Buy |
18,438
+2,070
| +13% | +$440K | 0.71% | 51 |
|
|
2020
Q3 | $2.81M | Sell |
16,368
-4,641
| -22% | -$796K | 0.61% | 55 |
|
|
2020
Q2 | $4.03M | Buy |
21,009
+681
| +3% | +$131K | 0.96% | 29 |
|
|
2020
Q1 | $2.99M | Buy |
+20,328
| New | +$2.99M | 0.7% | 37 |
|
|
2016
Q1 | – | Sell |
-3,800
| Closed | -$204K | – | 286 |
|
|
2015
Q4 | $204K | Buy |
+3,800
| New | +$204K | 0.02% | 207 |
|
|
2014
Q1 | – | Sell |
-4,331
| Closed | -$203K | – | 344 |
|
|
2013
Q4 | $203K | Sell |
4,331
-790,108
| -99% | -$37M | 0.01% | 301 |
|
|
2013
Q3 | $42M | Sell |
794,439
-6,933
| -0.9% | -$366K | 1.24% | 44 |
|
|
2013
Q2 | $36.2M | Buy |
+801,372
| New | +$36.2M | 1.72% | 31 |
|